Skip to main content
University of California San Francisco
UCSF School of Medicine | Department of Pediatrics UCSF Medical Center

Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment.

  • Read more about Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment.

Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States.

  • Read more about Comparing frequency of booster vaccination to prevent severe COVID-19 by risk group in the United States.

The antibiotic resistance reservoir of the lung microbiome expands with age in a population of critically ill patients.

  • Read more about The antibiotic resistance reservoir of the lung microbiome expands with age in a population of critically ill patients.

The USP46 complex deubiquitylates LRP6 to promote Wnt/β-catenin signaling.

  • Read more about The USP46 complex deubiquitylates LRP6 to promote Wnt/β-catenin signaling.

Feasibility of an implantable bioreactor for renal cell therapy using silicon nanopore membranes.

  • Read more about Feasibility of an implantable bioreactor for renal cell therapy using silicon nanopore membranes.

UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma.

  • Read more about UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma.

Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.

  • Read more about Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication.

Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability.

  • Read more about Loss of phosphatase CTDNEP1 potentiates aggressive medulloblastoma by triggering MYC amplification and genomic instability.

Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma.

  • Read more about Smarcd3 is an epigenetic modulator of the metabolic landscape in pancreatic ductal adenocarcinoma.

Systematic analysis and prediction of genes associated with monogenic disorders on human chromosome X.

  • Read more about Systematic analysis and prediction of genes associated with monogenic disorders on human chromosome X.

Pagination

  • Previous page ‹‹
  • Page 2
  • Next page ››
Subscribe to Nature communications

Pediatrics Home

MAKE A GIFT

© 2022 The Regents of the University of California. The University of California San Francisco  |  UCSF Department of Pediatrics                                                                                              Accessibility  Privacy Policy  Terms of Use  A-Z Website List